Monitoring fibrinolysis in whole blood by viscoelastic instruments: A comparison of ROTEM and ReoRox

References

• Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008;64:1211–7.
   PubMedGoogle Scholar
• Levi M, Meijers JC. DIC: which laboratory tests are most useful. Blood Rev 2011;25:33–7.
   PubMed Web of Science ®Google Scholar
• Ahonen J, Stefanovic V, Lassila R. Management of post-partum haemorrhage. Acta Anaesthesiol Scand 2010;54: 1164–78.
   PubMed Web of Science ®Google Scholar
• Porte RJ, Bontempo FA, Knot EA, Lewis JH, Kang YG, Starzl TE. Systemic effects of of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 1989;47:978–84.
   PubMed Web of Science ®Google Scholar
• Sniecinski RM, Chandler WL. Activation of the haemostatic system during cardiopulmonary bypass. Anesth Analg 2011; 113:1319–33.
   PubMed Web of Science ®Google Scholar
• Murray V, Norrving B, Sandercock PA, Terént A, Wardlaw JM, Wester P. The molecular basis of thrombolysis and its clinical application in stroke. J Intern Med 2010; 267:191–208.
   PubMed Web of Science ®Google Scholar
• Lankeit M, Konstantinides S. Thrombolysis for pulmonary embolism: past, present and future. Thromb Haemost 2010;103:877–83.
   PubMed Web of Science ®Google Scholar
• Tubaro M, Sonia Petronio A. ST-segment elevation myocardial infarction management in Europe. J Cardiovasc Med (Hagerstown) 2009;10(Suppl. 1):3–6.
   Web of Science ®Google Scholar
• Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008;106:1366–75.
   PubMed Web of Science ®Google Scholar
• Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008;100:792–7.
   PubMed Web of Science ®Google Scholar
• Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifert B, Simmen HP, Spahn DR, Baulig W. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011;113:1003–12.
   PubMed Web of Science ®Google Scholar
• Tauber H, Innerhofer P, Breitkopf R, Westermann I, Beer R, El Attal R, Strasak A, Mittermayr M. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the ‘Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study’. Br J Anaesth 2011; 107:378–87.
   PubMed Web of Science ®Google Scholar
• Stancheva A, Spassov L, Tzatchev K. Correlation between rotation thromboelastometry ROTEM analysis and standard haemostatic parameters during liver transplantation. Clin Lab 2011;57:407–13.
   PubMed Web of Science ®Google Scholar
• Vanek T, Jares M, Snircova J, Maly M. Fibrinolysis in coronary artery surgery: detection by thromboelastography. Interact Cardiovasc Thorac Surg 2007;6:700–4.
   PubMedGoogle Scholar
• Afshari A, Wikkelsø A, Brok J, Møller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011;16;(3): CD007871.
   Google Scholar
• Tynngård N, Lindahl T, Ramström S, Berlin G. Effects of different blood components on clot retraction analysed by measuring elasticity with a free oscillating rheometer. Platelets 2006;17:545–54.
   PubMed Web of Science ®Google Scholar
• Ramström S, Rånby M, Lindahl TL. Effects of inhibition of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry. Thromb Res 2003;109:315–22.
   PubMed Web of Science ®Google Scholar
• Nielsen VG, Cohen BM, Cohen E. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation. Blood Coagul Fibrinolysis 2006;17:75–81.
   PubMed Web of Science ®Google Scholar
• Bolliger D, Seeberger MD, Tanaka KA. Priniples and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 2012;26:1–13.
   PubMed Web of Science ®Google Scholar
• Genét GF, Ostrowski SR, Sørensen AM, Johansson P. Detection of tPA-induced hyperfibrinolysis in whole blood by RapidTEG, KaolinTEG, and functional fibrinogenTEG in healthy individuals. Clin Appl Thromb Hemost 2012; 18:638–44.
   PubMed Web of Science ®Google Scholar
• Sølbeck S, Windeløv NA, Bæk NH, Nielsen JD, Ostrowski SR, Johansson PI. In-vitro comparison of free oscillation rheometry (ReoRox) and rotational thrombelastometry (ROTEM) in trauma patients upon hospital admission. Blood Coagul Fibrinolysis 2012;23:688–92.
   PubMed Web of Science ®Google Scholar
• Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De'ath H, Allard S, Hart D, John Pasi K, Hunt BJ, Stanworth S, Maccallum P, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013;11:307–14.
   PubMed Web of Science ®Google Scholar
• Koh SC, Yuen R, Viegas OA, Chua SE, Ng BL, Sen DK, Ratnam SS. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females. Thromb Haemost 1991;66:581–5.
   PubMed Web of Science ®Google Scholar
• Summaria L. Thromboelastographic study of fibrinolytic agents. Semin Thromb Hemost 1995;21(Suppl. 4):63–71.
   PubMedGoogle Scholar
• Ostrowski SR, Sørensen AM, Larsen CF, Johansson PI. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study. Scand J Trauma Resusc Emerg Med 2011;19:64–74.
   PubMed Web of Science ®Google Scholar
• Tanswell P, Seifried E, Su PC, Feuerer W, Rijken DC. Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects. Clin Pharmacol Ther 1989;46:155–62.
   PubMed Web of Science ®Google Scholar
• Fox KA, Robison AK, Knabb RM, Rosamond TL, Sobel BE, Bergmann SR. Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator. Circulation 1985;72:1346–54.
   PubMed Web of Science ®Google Scholar
• Smith C, Al-Nuaimi Y, Wainwright J, Sherrington C, Singh A, Kallingal J, Douglass C, Parry-Jones A, Smith C, Dixit A, Majid A. The influence of bolus to infusion delays on plasma Tissue Plasminogen Activator levels. Int J Stroke. 2012 Dec 4. Accepted article.
   Web of Science ®Google Scholar